A detailed history of Tradewinds Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 151 shares of AMGN stock, worth $48,202. This represents 0.01% of its overall portfolio holdings.

Number of Shares
151
Previous 211 28.44%
Holding current value
$48,202
Previous $65,000 26.15%
% of portfolio
0.01%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$309.38 - $337.38 $18,562 - $20,242
-60 Reduced 28.44%
151 $48,000
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $16,132 - $19,473
60 Added 39.74%
211 $59,000
Q1 2023

Apr 10, 2023

SELL
$225.79 - $275.2 $9,708 - $11,833
-43 Reduced 22.16%
151 $36,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $9,848 - $12,513
43 Added 28.48%
194 $0
Q2 2022

Jul 21, 2022

SELL
$230.71 - $256.74 $1.42 Million - $1.58 Million
-6,159 Reduced 97.61%
151 $37,000
Q1 2022

Apr 25, 2022

BUY
$219.27 - $242.57 $1,096 - $1,212
5 Added 0.08%
6,310 $1.53 Million
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $52,902 - $60,541
-266 Reduced 4.05%
6,305 $1.42 Million
Q3 2021

Nov 04, 2021

SELL
$212.27 - $248.7 $1,910 - $2,238
-9 Reduced 0.14%
6,571 $1.4 Million
Q2 2021

Jul 30, 2021

BUY
$233.58 - $259.14 $934 - $1,036
4 Added 0.06%
6,580 $1.6 Million
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $887 - $1,034
4 Added 0.06%
6,576 $1.64 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $865 - $1,030
4 Added 0.06%
6,572 $1.51 Million
Q3 2020

Oct 26, 2020

BUY
$234.65 - $260.95 $703 - $782
3 Added 0.05%
6,568 $1.67 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $36,397 - $44,664
-184 Reduced 2.73%
6,565 $1.55 Million
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $124,105 - $164,597
681 Added 11.22%
6,749 $1.37 Million
Q4 2019

Feb 04, 2020

SELL
$189.21 - $243.2 $11,920 - $15,321
-63 Reduced 1.03%
6,068 $1.46 Million
Q3 2019

Oct 17, 2019

BUY
$174.11 - $208.62 $10,968 - $13,143
63 Added 1.04%
6,131 $1.19 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $2,667 - $3,126
-16 Reduced 0.26%
6,068 $1.12 Million
Q1 2019

Apr 23, 2019

SELL
$180.87 - $203.88 $6,511 - $7,339
-36 Reduced 0.59%
6,084 $1.16 Million
Q4 2018

Jan 31, 2019

SELL
$178.4 - $208.25 $116,316 - $135,779
-652 Reduced 9.63%
6,120 $1.19 Million
Q3 2018

Oct 31, 2018

BUY
$185.29 - $208.89 $5,002 - $5,640
27 Added 0.4%
6,772 $1.4 Million
Q2 2018

Aug 06, 2018

BUY
$166.05 - $186.51 $664 - $746
4 Added 0.06%
6,745 $1.25 Million
Q1 2018

May 02, 2018

BUY
$169.43 - $198.0 $11,351 - $13,266
67 Added 1.0%
6,741 $1.15 Million
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $1,350 - $1,508
8 Added 0.12%
6,674 $1.16 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $1.12 Million - $1.27 Million
6,666
6,666 $1.24 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.